Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis
Open Access
- 23 May 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1175409
Abstract
The apicomplexan parasite Toxoplasma gondii is the causative agent of toxoplasmosis, a global disease that significantly impacts human health. The clinical manifestations are mainly observed in immunocompromised patients, including ocular damage and neuronal alterations leading to psychiatric disorders. The congenital infection leads to miscarriage or severe alterations in the development of newborns. The conventional treatment is limited to the acute phase of illness, without effects in latent parasites; consequently, a cure is not available yet. Furthermore, considerable toxic effects and long-term therapy contribute to high treatment abandonment rates. The investigation of exclusive parasite pathways would provide new drug targets for more effective therapies, eliminating or reducing the side effects of conventional pharmacological approaches. Protein kinases (PKs) have emerged as promising targets for developing specific inhibitors with high selectivity and efficiency against diseases. Studies in T. gondii have indicated the presence of exclusive PKs without homologs in human cells, which could become important targets for developing new drugs. Knockout of specific kinases linked to energy metabolism have shown to impair the parasite development, reinforcing the essentiality of these enzymes in parasite metabolism. In addition, the specificities found in the PKs that regulate the energy metabolism in this parasite could bring new perspectives for safer and more efficient therapies for treating toxoplasmosis. Therefore, this review provides an overview of the limitations for reaching an efficient treatment and explores the role of PKs in regulating carbon metabolism in Toxoplasma, discussing their potential as targets for more applied and efficient pharmacological approaches.Keywords
This publication has 170 references indexed in Scilit:
- Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse populationEuropean Journal of Public Health, 2012
- Epidemiology of and Diagnostic Strategies for ToxoplasmosisClinical Microbiology Reviews, 2012
- Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondiiJournal of Experimental Medicine, 2011
- Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversionParasitology Research, 2010
- Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsNature Structural & Molecular Biology, 2010
- A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan FragmentsCell, 2008
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerBritish Journal of Cancer, 2008
- Carbohydrate Metabolism in theToxoplasma gondiiApicoplast: Localization of Three Glycolytic Isoenzymes, the Single Pyruvate Dehydrogenase Complex, and a Plastid Phosphate TranslocatorEukaryotic Cell, 2007
- Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2006
- The origins of protein phosphorylationNature Cell Biology, 2002